Eindhoven, Netherlands

Mariska De Smet

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Koninklijke Philips Corporation N.v.. Active years: 2017.


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mariska De Smet: Innovator in Drug Delivery Systems

Introduction

Mariska De Smet is a prominent inventor based in Eindhoven, Netherlands. She has made significant contributions to the field of drug delivery systems, particularly through her innovative work on lipid bilayer carriers.

Latest Patents

Mariska holds a patent for a "Lipid bilayer carrier for drugs or imaging agents." This patent discloses carriers designed for drugs and/or MR imaging agents, featuring a lipid bilayer shell made up of phospholipids. These phospholipids consist of two terminal alkyl chains, one being a short chain with a maximum length of seven carbon atoms, and the other being a long chain with a minimum length of fifteen carbon atoms. The combination of long and short chain phospholipids allows for the tuning of the release properties of the carrier. Preferred phospholipids for this application are phosphatidylcholines. She has 1 patent to her name.

Career Highlights

Mariska is currently employed at Koninklijke Philips Corporation N.V., where she continues to advance her research in drug delivery technologies. Her work has the potential to significantly impact the medical field by improving the efficacy of drug delivery systems.

Collaborations

Some of her notable coworkers include Sander Langereis and Holger Gruell, who collaborate with her on various projects within the company.

Conclusion

Mariska De Smet is a trailblazer in the field of drug delivery systems, with her innovative patent showcasing her expertise and dedication to advancing medical technology. Her contributions are paving the way for future developments in this critical area.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…